StockData
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31

NORTHWEST BIOTHERAPEUTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026

Market cap
$254.79M
P/E (TTM)
–
Dividend yield
–

NORTHWEST BIOTHERAPEUTICS INC revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Northwest Biotherapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.